
bit.bio
bit.bio is an award-winning human synthetic biology enterprise. Our mission is coding cells for health. To do so, we apply the principles of computation to biology. Our current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. This has the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modelling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious and driven by a common purpose.

Kinomica
Kinomica is a pioneering precision medicine research and diagnostics company specialising in cell signalling with an interdisciplinary phosphoproteomics platform that combines LC–MS/MS with advanced proprietary bioinformatics to provide bespoke R&D and diagnostic services.

Mawdsley-Brooks Co Ltd
Mawdsleys are a UK based pharmaceutical wholesaler and leading partner to the healthcare sector and pharmaceutical industry. They offer a range of services:
Pharmaceutical Industry:-
Pharma Third Party Logistics (3PL)
Named Patient Medicine Distribution
Clinical Trial Logistics (inc. blinding, randomisation, labelling, global distribution)
Clinical Trial Materials sourcing & manufacture (inc. IMPs, placebos, over encapsulation)
Regulatory Affairs Services (inc. QP Release / batch certification, QP Services, RP Services)
Patient Information Testing
Healthcare Sector:-
Wholesale Services to hospitals
International Sales
Unlicensed / Named Patient Medicine Supply
Clinical Trial Supply to hospitals and academia (inc. placebos)
Pharmaceutical Overlabelling
Pharmacy IT systems

ProImmune
ProImmune’s mission is to be your partner of choice for understanding and managing adaptive immune responses. We offer unique solutions for preclinical and clinical immunology research, including a comprehensive and integrated antigen characterization platform, and products and services for tracking antigen-specific immune responses with state-of-the-art ELISpot and flow cytometry techniques. We are committed to helping you take your studies to success through product innovation, responsive service and focused application support, saving you time and money and reducing risk.

Sekisui
Headquartered in Burlington, MA, for 40 years SEKISUI Diagnostics has been committed to helping improve the lives of patients by providing innovative medical diagnostics to physicians and laboratories. We continue to invest in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems, and have a leading position as a provider of rapid tests in the US and high throughput coagulation systems in Japan. Our workforce spans six sites located in four countries. We are a sister company to SEKISUI Medical in Japan, making us a worldwide company with R&D and Manufacturing facilities on three continents. We develop, manufacture, and supply billions of tests each year to the global healthcare market through our commercial networks and partners.
Our product lines include:
- Clinical chemistry reagents
- Coagulation reagents
- Point-of-care rapid tests and immunoassay system
- Enzymes and specialty biochemicals

Veratrak
At Veratrak we are transforming the way the pharmaceutical supply chain works together to deliver high quality and cost effective health care.
Veratrak is a document and workflow management platform that allows pharmaceutical supply chain companies to communicate and work together with their customers and suppliers with greater efficiency, security, and auditability.